http://purl.org/np/RAxyys0B68... RAxyys0B68

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T12:27:17.243Z

http://purl.org/np/RAxyys0B68... RAxyys0B68

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T12:27:17.243405

Elif Ozkan

2022-10-13T12:27:17.243Z

http://purl.org/np/RAxyys0B68... RAxyys0B68

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. The tablets are available as a combination or complete regimen for adults and children weighing more than 40 kg.

Elif Ozkan

2022-10-13T12:27:17.243Z